Small Intestinal Bacterial Overgrowth is a condition in which bacteria are present in the small intestine in excessive numbers or in an abnormal composition relative to normal intestinal ecology. The small intestine normally contains substantially fewer bacteria than the colon, partly because gastric acid, intestinal motility, anatomical barriers, bile and pancreatic secretions help regulate microbial populations. When these protective mechanisms are disrupted, bacteria can multiply or colon-type organisms can occupy regions where they are normally less abundant. The resulting microbial activity can alter digestion and fermentation, generate excessive gas and interfere with nutrient absorption. The term describes a microbial state associated with gastrointestinal dysfunction rather than a single disease with one universal cause.
Symptoms commonly include abdominal bloating, excessive gas, abdominal discomfort, diarrhoea and altered bowel habits. Some people develop weight loss or nutritional deficiencies when bacterial overgrowth becomes sufficiently significant to interfere with nutrient handling. The severity of symptoms does not necessarily correspond precisely to bacterial quantity, because microbial composition, intestinal motility, food intake and individual visceral sensitivity all influence the clinical picture. Symptoms overlap substantially with irritable bowel syndrome, carbohydrate malabsorption and other gastrointestinal conditions. Consequently, bloating and diarrhoea alone cannot establish Small Intestinal Bacterial Overgrowth, and diagnosis requires consideration of the underlying risk factors and appropriate testing.
Conditions that slow intestinal movement or alter intestinal anatomy can predispose to overgrowth. Examples include disorders of intestinal motility, structural abnormalities, surgical alterations, short-bowel states and chronic intestinal pseudo-obstruction. When intestinal contents move too slowly, bacteria have more opportunity to proliferate in the small bowel. Anatomical blind loops or altered connections can similarly permit bacterial accumulation. Reduced protective mechanisms or other gastrointestinal disorders may contribute. SIBO can therefore be a consequence of another condition rather than the primary disorder, which is why treating only the bacterial overgrowth without addressing the predisposing mechanism can result in recurrence.
Bacterial overgrowth can affect digestion and nutrient availability through several mechanisms. Bacteria ferment carbohydrates before they are normally handled by the distal intestine, producing hydrogen and, depending on the microbial population, other gases. Bacteria can alter bile acids, interfere with fat digestion and contribute to malabsorption of fat and fat-soluble vitamins. Competition for nutrients and altered metabolism can contribute to nutritional deficiency in more severe cases. Chronic or substantial overgrowth may therefore cause more than bloating: it can contribute to diarrhoea, weight loss, weakness and measurable nutritional impairment. These mechanisms explain the association between SIBO and broader malabsorption syndromes.
Diagnosis commonly involves breath testing using a carbohydrate substrate such as glucose or lactulose, with serial measurement of gases produced by bacterial metabolism. Hydrogen breath testing can also be used to investigate lactose and fructose malabsorption, but the interpretation of these tests requires awareness of intestinal transit and the possibility of false-positive or false-negative results. Some specialist settings have used direct sampling of small-intestinal contents, but invasive sampling is not routinely practical. Test methodology, preparation and clinical context matter because symptoms such as bloating are nonspecific. A positive breath result should therefore be interpreted alongside the patient's history and predisposing conditions rather than treated as an isolated definitive explanation for every gastrointestinal complaint.
Treatment generally involves addressing the underlying cause and, when clinically appropriate, reducing the bacterial overgrowth with antimicrobial therapy. Antibiotics may be prescribed to alter the excessive bacterial population, sometimes requiring tailored or repeated treatment when symptoms recur. Nutritional deficiencies may require replacement, and dietary modification can help manage symptoms in selected patients. However, extreme dietary restriction is not a substitute for determining why bacterial overgrowth developed. If abnormal motility, intestinal obstruction, anatomical alteration or another underlying condition persists, recurrence can occur. Management therefore works best when antimicrobial treatment and correction or control of the predisposing physiological problem are considered together.
Small Intestinal Bacterial Overgrowth has important relationships with intestinal motility, malabsorption and carbohydrate intolerance. Slow transit can encourage bacterial proliferation, while the resulting fermentation can increase symptoms after carbohydrate ingestion. SIBO can complicate hydrogen breath testing for lactose or fructose intolerance and may produce apparent carbohydrate malabsorption because bacteria metabolise substrates before they reach their usual site of absorption. Chronic intestinal pseudo-obstruction is an important example of a disorder that can predispose to SIBO and, in turn, to nutritional complications. Short-bowel syndrome can also be associated with bacterial overgrowth because altered intestinal anatomy and motility affect the microbial environment.
A common misconception is that SIBO is simply the presence of any bacteria in the small intestine; small numbers of bacteria normally exist there, so the clinically relevant concept concerns excessive numbers or abnormal microbial distribution. Another misconception is that every case of bloating represents SIBO. Symptoms overlap with numerous other gastrointestinal conditions, and indiscriminate testing or repeated antimicrobial treatment can fail to address the actual cause. SIBO is most useful clinically as part of a broader model involving motility, anatomy, digestion, absorption and microbial ecology. Successful long-term management therefore depends not only on reducing bacterial overgrowth when indicated but also on identifying the physiological circumstances that allowed it to develop.
